- Home
- OKUR vs PYPD Comparison
OKUR vs PYPD Comparison
Compare OKUR & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKUR
- PYPD
- Stock Information
- Founded
- OKUR 2011
- PYPD 2008
- Country
- OKUR United States
- PYPD Israel
- Employees
- OKUR N/A
- PYPD N/A
- Industry
- OKUR
- PYPD Medical/Dental Instruments
- Sector
- OKUR
- PYPD Health Care
- Exchange
- OKUR NYSE
- PYPD Nasdaq
- Market Cap
- OKUR 34.9M
- PYPD 36.0M
- IPO Year
- OKUR N/A
- PYPD 2020
- Fundamental
- Price
- OKUR $2.52
- PYPD $3.40
- Analyst Decision
- OKUR Strong Buy
- PYPD Strong Buy
- Analyst Count
- OKUR 4
- PYPD 5
- Target Price
- OKUR $32.25
- PYPD $11.40
- AVG Volume (30 Days)
- OKUR 69.8K
- PYPD 214.9K
- Earning Date
- OKUR 08-14-2025
- PYPD 08-13-2025
- Dividend Yield
- OKUR N/A
- PYPD N/A
- EPS Growth
- OKUR N/A
- PYPD N/A
- EPS
- OKUR N/A
- PYPD N/A
- Revenue
- OKUR N/A
- PYPD N/A
- Revenue This Year
- OKUR N/A
- PYPD N/A
- Revenue Next Year
- OKUR N/A
- PYPD N/A
- P/E Ratio
- OKUR N/A
- PYPD N/A
- Revenue Growth
- OKUR N/A
- PYPD N/A
- 52 Week Low
- OKUR $1.70
- PYPD $2.30
- 52 Week High
- OKUR $20.00
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- OKUR N/A
- PYPD 51.00
- Support Level
- OKUR N/A
- PYPD $3.34
- Resistance Level
- OKUR N/A
- PYPD $3.53
- Average True Range (ATR)
- OKUR 0.00
- PYPD 0.15
- MACD
- OKUR 0.00
- PYPD -0.04
- Stochastic Oscillator
- OKUR 0.00
- PYPD 14.68
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.